Brenton L. Saunders

2017

In 2017, Brenton L. Saunders earned a total compensation of $32.8M as Chairman, President and Chief Executive Officer at Allergan, a 693% increase compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$249
Non-Equity Incentive Plan$8,752,500
Salary$1,232,822
Stock Awards$22,682,025
Other$160,030
Total$32,827,626

Saunders received $22.7M in stock awards, accounting for 69.09% of the total pay in 2017.

Saunders also received $249 of change in pension value and nonqualified deferred compensation earnings, $8.8M in non-equity incentive plan, $1.2M in salary and $160K in other compensation.

Overall ranking

Ranking

50

out of 13,853
Percentile100th

Brenton L. Saunders' 2017 compensation ranked 50th out of 13,853 executive pay records tracked by us this year.

Saunders earned more than 99.6% of all executives tracked by us in 2017.

Ranking in industry group

Industry groupDrugs
Ranking

3

out of 1,584
Percentile100th

In the industry group of Drugs, Saunders' pay ranked 3rd out of 1,584 executive pay records tracked by us in 2017.

Saunders earned more than 99.8% of executives in this group.

Source: SEC filing on March 23, 2018.

Saunders' colleagues

We found four more compensation records of executives who worked with Brenton L. Saunders at Allergan in 2017.

2017

William Meury

Allergan

Chief Commercial Officer

2017

C Nicholson

Allergan

Chief R&D Officer

2017

Maria Hilado

Allergan

Chief Financial Officer

2017

Robert Stewart

Allergan

Chief Operating Officer

News

You may also like